Literature DB >> 19890045

Cutting edge: memory CD8 T cell compartment grows in size with immunological experience but nevertheless can lose function.

Katharina M Huster1, Christian Stemberger, Georg Gasteiger, Wolfgang Kastenmüller, Ingo Drexler, Dirk H Busch.   

Abstract

The size of the adaptive immune system is considered to be kept constant by the attrition of pre-existing memory. However, recently it was shown that the CD8 memory compartment can grow in size and the number of pre-existing memory is largely preserved, predicting that pre-existing immunity should be maintained (Vezys et al.; Nature 457: 196-199). Experimental proof for this assumption is still lacking. We address this question in the Listeria monocytogenes (L.m.) infection model and confirm the growth of size of the memory compartment by subsequent vaccination with modified vaccinia virus Ankara. We also find only modest attrition of pre-existing L.m.-specific memory CD8 T cells. However, pre-existing protective immunity toward L.m. is not preserved. Pre-existing L.m.-specific effector-memory cells, in contrast to central memory cells, become altered, and this results in a significant loss of pre-existing protective immunity. Our findings are clinically relevant for vaccines introducing new CD8 memory cells in high numbers, as this might influence pre-existing immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890045     DOI: 10.4049/jimmunol.0902454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

Review 2.  Immune memory and aging: an infinite or finite resource?

Authors:  Janko Nikolich-Zugich; Brian D Rudd
Journal:  Curr Opin Immunol       Date:  2010-07-30       Impact factor: 7.486

3.  Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization.

Authors:  Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

4.  Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.

Authors:  Paula Ordonhez Rigato; Bruna C de Alencar; José Ronnie C de Vasconcelos; Mariana R Dominguez; Adriano F Araújo; Alexandre V Machado; Ricardo T Gazzinelli; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

5.  Distinct effects of saracatinib on memory CD8+ T cell differentiation.

Authors:  Shinji Takai; Helen Sabzevari; Benedetto Farsaci; Jeffrey Schlom; John W Greiner
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.422

6.  Effector-like CD8⁺ T cells in the memory population mediate potent protective immunity.

Authors:  Janelle A Olson; Cameron McDonald-Hyman; Stephen C Jameson; Sara E Hamilton
Journal:  Immunity       Date:  2013-06-06       Impact factor: 31.745

Review 7.  Interactions between innate and adaptive lymphocytes.

Authors:  Georg Gasteiger; Alexander Y Rudensky
Journal:  Nat Rev Immunol       Date:  2014-08-18       Impact factor: 53.106

Review 8.  From the thymus to longevity in the periphery.

Authors:  Linda M Wakim; Michael J Bevan
Journal:  Curr Opin Immunol       Date:  2010-04-06       Impact factor: 7.486

9.  Theoretical analysis of the evolution of immune memory.

Authors:  Frederik Graw; Carsten Magnus; Roland R Regoes
Journal:  BMC Evol Biol       Date:  2010-12-08       Impact factor: 3.260

10.  Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination.

Authors:  José R Vasconcelos; Mariana R Dominguez; Adriano F Araújo; Jonatan Ersching; Cibele A Tararam; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Front Immunol       Date:  2012-12-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.